Evidence map›Paper›PMID 37657519›Full record

ArticleMolecular & cellular proteomics : MCP2023

A Multipathway Phosphopeptide Standard for Rapid Phosphoproteomics Assay Development.

Brian C Searle, Allis Chien, Antonius Koller, David Hawke, Anthony W Herren, Jenny Kim Kim, Kimberly A Lee, Ryan D Leib, Alissa J Nelson, Purvi Patel and 5 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. A framework for quality control in quantitative proteomics.bioRxiv : the preprint server for biology · 2024
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Brian C SearleDepartment of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA. Electronic address: brian.searle@osumc.edu.
Allis ChienMass Spectrometry Center, Stanford University, Stanford, California, USA.
Antonius KollerYatiriBio, San Diego, California, USA.
David HawkeBreakBio Corp, New York, New York, USA.
Anthony W HerrenUC Davis Genome Center, Proteomics Core, University of California Davis, Davis California, USA.
Jenny Kim KimHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA.
Kimberly A LeeCell Signaling Technology, Inc, Danvers, Massachusetts, USA.
Ryan D LeibMass Spectrometry Center, Stanford University, Stanford, California, USA.
Alissa J NelsonCell Signaling Technology, Inc, Danvers, Massachusetts, USA.
Purvi PatelHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA.
Jian Min RenCell Signaling Technology, Inc, Danvers, Massachusetts, USA.
Paul M StemmerDepartment of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan, USA.
Yiying ZhuCell Signaling Technology, Inc, Danvers, Massachusetts, USA.
Benjamin A NeelyNational Institute of Standards and Technology, Charleston, South Carolina, USA.
Bhavin PatelThermo Fisher Scientific, Rockford, Illinois, USA.

Funding

Investigating the functional impact of genetic variants in the human proteomeR35GM150723 · NIGMS · OHIO STATE UNIVERSITY · PI Brian Chih-Seng Searle · 2023 to 2026
$1.6M
A universal multiplexing approach to unlock the hidden proteomeR01GM133981 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SWANEY, DANIELLE L · 2019 to 2022
$1.3M
NIGMS NIH HHS R01 GM133981NIGMS NIH HHS R35 GM150723
6 · The paper itself

Abstract

Recent advances in methodology have made phosphopeptide analysis a tractable problem for many proteomics researchers. There are now a wide variety of robust and accessible enrichment strategies to generate phosphoproteomes while free or inexpensive software tools for quantitation and site localization have simplified phosphoproteome analysis workflow tremendously. As a research group under the Association for Biomolecular Resource Facilities umbrella, the Proteomics Standards Research Group has worked to develop a multipathway phosphopeptide standard based on a mixture of heavy-labeled phosphopeptides designed to enable researchers to rapidly develop assays. This mixture contains 131 mass spectrometry vetted phosphopeptides specifically chosen to cover as many known biologically interesting phosphosites as possible from seven different signaling networks: AMPK signaling, death and apoptosis signaling, ErbB signaling, insulin/insulin-like growth factor-1 signaling, mTOR signaling, PI3K/AKT signaling, and stress (p38/SAPK/JNK) signaling. Here, we describe a characterization of this mixture spiked into a HeLa tryptic digest stimulated with both epidermal growth factor and insulin-like growth factor-1 to activate the MAPK and PI3K/AKT/mTOR pathways. We further demonstrate a comparison of phosphoproteomic profiling of HeLa performed independently in five labs using this phosphopeptide mixture with data-independent acquisition. Despite different experimental and instrumentation processes, we found that labs could produce reproducible, harmonized datasets by reporting measurements as ratios to the standard, while intensity measurements showed lower consistency between labs even after normalization. Our results suggest that widely available, biologically relevant phosphopeptide standards can act as a quantitative "yardstick" across laboratories and sample preparations enabling experimental designs larger than a single laboratory can perform. Raw data files are publicly available in the MassIVE dataset MSV000090564.

Indexed as

PhosphopeptidesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPhosphoproteinsPhosphorylationTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesPhosphopeptidesPhosphoproteinsProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinasesdata-independent acquisitionmass spectrometryphosphopeptidephosphorylationproteomicsstable isotope labeltargeted

Identifiers

PMID37657519
PMCPMC10561125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.